Studies of nanoparticle delivery with <i>in vitro</i> bio-engineered microtissues.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32637755.
- Also identified by DOI 10.1016/j.bioactmat.2020.06.016 and PMC identifier 7330434.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A variety of engineered nanoparticles, including lipid nanoparticles, polymer nanoparticles, gold nanoparticles, and biomimetic nanoparticles, have been studied as delivery vehicles for biomedical applications. When assessing the efficacy of a nanoparticle-based delivery system, <i>in vitro</i> testing with a model delivery system is crucial because it allows for real-time, <i>in situ</i> quantitative transport analysis, which is often difficult with <i>in vivo</i> animal models. The advent of tissue engineering has offered methods to create experimental models that can closely mimic the 3D microenvironment in the human body. This review paper overviews the types of nanoparticle vehicles, their application areas, and the design strategies to improve delivery efficiency, followed by the uses of engineered microtissues and methods of analysis. In particular, this review highlights studies on multicellular spheroids and other 3D tissue engineering approaches for cancer drug development. The use of bio-engineered tissues can potentially provide low-cost, high-throughput, and quantitative experimental platforms for the development of nanoparticle-based delivery systems.